Established in 2018, CERES F&D is a biopharmaceutical company that produces high quality, effective medicines. Our commitment to quality includes continuously maintaining the highest standards, developing efficient technology, and investing in new products. We are manufacturing Antibiotics, Immunosuppressant APIs and have global rights for Alteogen's commercialized products (Tergase®), human hyaluronidase. We are subsidiary of Alteogen, leading bio company in Korea.